Why Tilray Shares Are Jumping

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why Tilray Shares Are Jumping

© Thinkstock

Tilray Inc. (NASDAQ: TLRY) shares jumped on Thursday after the firm made a couple updates to its business. First, Tilray announced that it has made a few additions to its global senior leadership team. Separately, the firm signed a long-term revenue-sharing agreement to market and distribute a portfolio of consumer cannabis products with Authentic Brands Group (ABG), in jurisdictions where regulations permit.

[in-text-ad]

Each of the recently hired senior leaders brings invaluable expertise to Tilray’s growing leadership team. The firm is adding: Greg Christopher as executive vice president (EVP) of Operations, formerly with Nestle; Rita Seguin as EVP of Human Resources, formerly with Diageo; Dara Redler as general counsel, formerly with Coca-Cola; and Charlie Cain as vice president of Retail, formerly with Starbucks.

ABG has a global retail footprint of over 100,000 points of sale and more than 4,500 branded freestanding stores and shop-in-shops. The firm’s portfolio generates roughly $9 billion in retail sales annually.

[nativounit]

Brendan Kennedy, Tilray president and CEO, commented:

We are thrilled to partner with ABG, a global leader known for expertly managing and marketing an owned portfolio of iconic brands. As we work to expand Tilray’s global presence, this agreement leverages our complementary strengths and will be accretive to our shareholders as we reach new consumers across the entertainment, fashion, beauty, home, and health and wellness sectors. We look forward to working with ABG to bring unique and sought-after branded cannabis products to the marketplace.

Excluding Thursday’s move, Tilray had outperformed the broad markets, with its stock up about 10% year to date.

Shares of Tilray were last seen up about 4% at $80.60 on Thursday, in a 52-week range of $20.10 to $300.00. The consensus price target is $131.25.

[recirclink id=525249]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618